|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:566
© 2005 The American Association for Thoracic Surgery
Brief Communication |
Department of Anesthesia, The Hospital for Sick Children, Toronto, Ontario, Canada
Received for publication December 15, 2004; accepted for publication January 3, 2005. * Address for reprints: Katherine Taylor, MD, Department of Anesthesia, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada (Email: ktaylor406{at}hotmail.com).
Current theories on nitric oxide and sepsis hypothesize that selective inhibition of guanylate cyclase may be beneficial in septic shock.
1
We present a case of refractory hypotension in a pediatric patient with native mitral valve endocarditis with cerebral complications in whom methylene blue was less effective than previously described.
2,3
Clinical Summary
A 10-year-old girl, weighing 32 kg, with no medical history was transferred from a regional center with Staphylococcal aureus native mitral valve endocarditis complicated by cerebral infarction and hemorrhage in both frontal lobes, the right thalamus, and possibly the left caudate nucleus and thalamus. She deteriorated day 2 of admission with chorda rupture, and an emergency mitral valve operation was indicated.
Standard anesthesia was administered. Preanesthesia inotropes were dopamine 10 µg · kg1 · min1 and epinephrine 0.5 µg · kg1 · min1. A bolus dose of 2 mg/kg of methylene blue was given. On commencement of cardiopulmonary bypass, a further 2 mg/kg and an infusion of 1 mg · kg1 · h1 of methylene blue was commenced. An abscess around the mitral valve annulus was resected and replaced with a porcine valve. The dilated left atrium and ventricle were reinforced with a bovine pericardial patch.
During bypass, mean arterial pressure was maintained between 30 and 40 mm Hg. Cerebral oximetry ranged from 76% to 93% prebypass during methylene blue infusion and from 66% to 82% during bypass. Surprisingly, methylene blue did not seem to affect oximetry readings. The CPB time was 133 minutes, and the aortic crossclamp time was 115 minutes. Weaning from bypass required epinephrine 0.05 to 0.1 µg · kg1 · min1, norepinephrine 0.1 µg · kg1 · min1, vasopressin 0.0001 to 0.0003 µg · kg1 · min1, milrinone 0.33 µg · kg1 · min1, and methylene blue infusion at 1 mg · kg1 · h1 to achieve a systolic arterial pressure of 70 to 80 mm Hg and diastolic pressure range of 30 to 50 mm Hg.
The patient was transferred to the critical care unit and extubated 6 days later. The methylene blue infusion was ceased on arrival to the unit. Epinephrine and norepinephrine were ceased the day after surgery, vasopressin was ceased on postoperative day 2, and milrinone was ceased on day 8.
Discussion
Septic shock is characterized by arterial hypotension associated with peripheral vasodilation and the early development of myocardial depression. Nitric oxide has been implicated in these derangements.
2,4
Exposure to endotoxin and cytokines can trigger a de novo synthesis of the inducible, calcium-dependent isoform of nitric oxide synthase. Methylene blue inhibits this process by decreasing intracellular cyclic guanosine monophosphate concentrations through guanylate cyclase inhibition, thus blocking its vasodilator properties.
1
Methylene blue increases arterial pressure, systemic vascular resistance, and left ventricular stroke work but does not increase cardiac output, oxygen delivery, or oxygen consumption.
4
The release of nitric oxide may be beneficial by increasing blood flow to ischemic areas, scavenging oxygen free radicals, and exerting microbiocidal properties.
2
Conclusion
A literature review revealed sporadic case reports and 1 prospective clinical trial in adults using methylene blue to treat the refractory hypotension in septic shock. A retrospective review estimated a mortality risk of 66.3% in 1 series for adult patients with infective endocarditis who had experienced cerebral infarction within 24 hours preceding cardiac surgery.
5
We present a pediatric case in which refractory hypotension from infective endocarditis was treated with methylene blue. The obvious clinical improvement using methylene blue in a previously published case report was not evident in this case, but her postoperative course was relatively benign.
2,3
Improvement of blood pressure does not necessarily correlate with improved tissue perfusion in the patient with sepsis, and we suggest this case report as further justification for larger scientifically controlled trials investigating methylene blue as an agent for refractory hypotension.
References
This article has been cited by other articles:
![]() |
A. J. C. Mittnacht Prolonged Decrease of Regional Cerebral Saturation Readings with the INVOS(R) Device After Continuous Intravenous Methylene Blue Administration Anesth. Analg., April 1, 2008; 106(4): 1327 - 1327. [Full Text] [PDF] |
||||
![]() |
R. A. Widman and M. D. Wider Prolonged Decrease of Regional Cerebral Saturation Readings with the INVOS(R) Device After Continuous Intravenous Methylene Blue Administration Anesth. Analg., April 1, 2008; 106(4): 1327 - 1327. [Full Text] [PDF] |
||||
![]() |
D. L. McDonagh, M. R. McDaniel, and T. G. Monk The Effect of Intravenous Indigo Carmine on Near-Infrared Cerebral Oximetry Anesth. Analg., September 1, 2007; 105(3): 704 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. C. Mittnacht, G. W. Fischer, and D. L. Reich Methylene Blue Administration Is Associated with Decreased Cerebral Oximetry Values Anesth. Analg., August 1, 2007; 105(2): 549 - 550. [Full Text] [PDF] |
||||
![]() |
P. R. B. Evora and A. J. Rodrigues Methylene blue revised J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 250 - 251. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |